Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156:1686.
Arana GW, Goff D, Baldessarini RJ, et al. The effect of anticholinergic prophylaxis on neuroleptic-induced dystonia. Am J Psychiatry 1988; 145:993.
Casey DE. Side effect profiles of new antipsychotic agents. J Clin Psychiatry 1996; 57(suppl 11):40.
Chouinard G, Annable L, Ross-Choiunard A, et al. A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases. J Clin Psychopharmacol 1988; 8(suppl):21.
Fleischhacker WW, Roth SD, Kane JM. The pharmacologic treatment of neuroleptic-induced akathisia. J Clin Psychopharmacol 1990; 10:12.
Fulop G, Phillips RA, Shapiro AK, et al. ECG changes during haloperidol and pimozide treatment of Tourette's disorder. Am J Psychiatry 1987; 144:673.
Gardos G, Casey DE, Cole JO, et al. Ten-year outcome of tardive dyskinesia. Am J Psychiatry 1994; 151:836.
Rosebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 1989; 146:717.
Rosenberg MR, Green M. Neuroleptic malignant syndrome: review of response to therapy. Arch Intern Med 1989; 149:1927.
.
Ciraulo D, Shader RI, Greenblatt DJ, et al. Drug interactions in psychiatry. Baltimore: Williams & Wilkins, 1995.
.
Jeste DV, Lacro JP, Bailey A, et al. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 1999; 47:7l6.
.
Cohen LS, Altshuler LL. Pharmacologic management of psychiatric illness during pregnancy and the postpartum period. Psychiatr Clin North Am 1997; 21:60.
Romeau-Rouguette C, Goujard J, Huel G. Possible teratogenic effect of phenothiazines in human beings. Teratology 1977; 15:57.
Sloane D, Siskind V, Heinonen OP, et al. Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol 1977; 128:486.
Spielvogel A, Wile J. Treatment and outcomes of psychotic patients during pregnancy and childbirth. Birth 1992; 19:3.
Viguera AC, Baldessarini RC. Neuroleptic withdrawal in schizophrenic patients. Arch Gen Psychiatry 1995; 52:189.
3. .
, .[24] , - () (. 3.1).
3.1
:
()
|
|
()
( )
( )
- ( )
( )
:
( , )
( )
( )
:
,
: (a) (); (b) () (, ); (c) (), (d) . (, , , , ). , , .
.
, , , . , . , , , . , , , , , . . , , , , . , . , , , .
, , , . , , , . , , . (. 3.1).
|
|
3.1. , () . . , , ; , . , .
. , . , , , , , . . , . , . , ( ) , 3 . 6 .
-, . , , . , . , , β1-, . α2- 5-HT2-. , , ( ), . , , . , . , .
, . , , , , (, , , ). , 1-, ( ). .
|
|
.
, , , , , . , , . , , , .
. , , , , , ( ) ( / ) . , , , . . , ( , ). , .
.
( ) , . , , . , . , , [25], . , , , , .
. . . , , , .
.
50% , , (DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edition), (. . 6 ). , 10-15% . , , , , . , .
|
|
, - 20-40% . , 2 , , -, . , , . - .
. , , [26] . , , (), . ( ) , , , . . , , , , , , .
.
, , . ; , , .
, . . , :
1. 30-50% . .
2. (, , , ).
, , , , . , . .
, . , , . , . , , II- (. . ). , . , , . , , ; . , , , , , . . , , . () , .
|
|
[27]
, A V. A , ; V , , , . , , () , , , (, ) . ( ), , . , . , . . . , .
.
, , . , . , , , , , . , , , . . , .
,
, , . . , , , . , , , , .
, , , . , , . , , , .
[28]
(, ) . , ( 70-80% ), (30-50% ). , , .
, , , , . , 4-6 , . (, , ) , . . , , . , P450 2D6. , , , , , . [29] , . . . [30], , ; .
. . , , .
, , , .[31] -, , .
(, ) . , , . , , . , , , .
, , . , , - . .